Total Adverse Events Gardasil (HPV4)was approved for use in
June 2006. This chart represents the vaccines most frequently
reported in the VAERS system versus all other vaccines listed in
the database since that time. It includes vaccinations given in
combination with other vaccines.
Slide 3
Total Reports in VAERS Once again, the most reported vaccines
in the VAERS database this time only those vaccines that were not
administered with any others. HPV4 is Gardasil.
Slide 4
Life Threatening Events: Female This and all of the following
charts compare the HPV vaccines Gardasil and Cervarix to the rest
of the vaccines in the VAERS database. Note that in the 12-17 age
group HPV vaccines account for 83% of all life threatening
events.
Slide 5
Life Threatening: Male HPV vaccines were approved for use in
males in November 2011. Already, you can see a significant
percentage of life-threatening events in the male population.
Slide 6
Life Threatening: Gender Unknown VAERS reports do not always
list the gender of the person reporting an adverse reaction after
vaccinations. This chart illustrates the breakdown of those
reports.
Slide 7
Life Threatening: Total Events View the percentages of all
life-threatening events in the VAERS database, without regard to
gender, when HPV vaccines are compared to all other reportable
vaccines.
Slide 8
Emergency Room Visits: Female Gardasil and Cervarix account for
between 34 and 73% of all female emergency room visits reported to
VAERS since HPV vaccines were approved by the FDA.
Slide 9
Emergency Room Visits: Male Male emergency room visits reported
after HPV vaccines compared to all other vaccines. Keep in mind
these only date from November 2011.
Slide 10
Emergency Room Visits: Gender Unknown Emergency room visits
where gender was not reported.
Slide 11
Emergency Room Visits: Total No matter which age group you look
at, Gardasil and Cervarix account for a significant percentage of
all ER visits reported VAERS database. Keep in mind, there are 77
other FDA approved vaccines in the VAERS database.
Slide 12
Hospitalized: Female Is there any reason that one type of
vaccine should ever account for 81% of the hospitalizations in a
specific age group of young women? Does this alone not raise a red
flag?
Slide 13
Hospitalized: Male Less than a year after HPV vaccines were
approved for use in males, between 1% and 6% of all reported male
hospitalizations are occurring after HPV vaccines.
Slide 14
Hospitalized: Gender Unknown One has to wonder how someone can
be hospitalized without knowing their gender, but these are the
percentages of that type of report to VAERS.
Slide 15
Hospitalized: Total 70% of all hospitalizations reported in the
12-17 year old group was after either Gardasil or Cervarix. What is
wrong with this picture?
Slide 16
Extended Hospital Stay: Female One has to ask why anyone would
risk an extended hospital stay to prevent HPV infections when 90%
of them clear on their own with no symptoms or medical
intervention.
Slide 17
Extended Hospital Stay: Male 76 vaccines and HPV vaccines
already account for 2-5% of extended hospital stays for males.
Slide 18
Extended Hospital Stay: Total Of all reported extended hospital
stays, Gardasil and Cervarix account for 34% of all reports in the
17-44 year old group even though these vaccines are not recommended
for anyone over age 26.
Slide 19
Did Not Recover: Female Why does a single type of vaccine
account for such a large percentage of did not recover events.
Slide 20
Did Not Recover: Male Males who have not recovered from new
medical conditions after vaccinations.
Slide 21
Did Not Recover: Gender Unknown 14-44% of the unknown gender
reports have not recovered from new medical conditions after HPV
vaccinations.
Slide 22
Did Not Recover: Total By FDA definition, any new medical
condition occurring after vaccination is an adverse event. Why is
such a large percentage of those who have not recovered being
reported after HPV vaccines?
Slide 23
Disabled: Female When looking at the next few charts, one has
to wonder what quality of life is left for those classified as
disabled after Gardasil or Cervarix vaccinations.
Slide 24
Disabled: Male This graph illustrates males who have become
disabled after HPV vaccines they took to either protect the women
they meet in the future, or protect themselves from genital warts
and/or rare forms of cancer.
Slide 25
Disabled: Gender Unknown There may not be many reports in this
area, but each of them was a person with a family left to cope with
the disability. These are real people.
Slide 26
Disabled: Total Well over 500 people who are left disabled
after HPV vaccines.
Slide 27
Serious: Female Considering the number of FDA approved
vaccines, there is no way two of them should account for such a
large percentage of serious adverse events.
Slide 28
Serious: Male Please remember males have not been taking HPV
vaccines for very long.
Slide 29
Serious: Gender Unknown What kind of hospital bills did these
families end up with in the name of protecting their children from
a disease they have very little chance of contracting?
Slide 30
Serious: Total Do the families of these victims still think the
benefits of HPV vaccination outweigh the risks?
Slide 31
Deaths: Female Families who have paid the ultimate price for
the greater good are told these deaths were coincidental,
population-based, just chance, or unexplainable.
Slide 32
Deaths: Male Additional acceptable collateral damage?
Slide 33
Deaths: Gender Unknown When will someone decide to actually
investigate these unexplained deaths?
Slide 34
Deaths: Total How can anyone discount these percentages? No one
knows what the true figures are. Even the CDC admits that only
1-10% of adverse reactions are actually reported to the Vaccine
Adverse Event Reporting System. When you add a zero or two to all
of the figures in the previous pages, the picture is not very
pretty. When will government health officials admit the advertised
benefits of HPV vaccines do not outweigh the real risks?
Slide 35
SaneVax would like to express a heartfelt thanks to Rosemary
Mathis and Janny Stokvis for compiling all of this data and
creating this set of revealing charts. We sincerely appreciate all
of the hard work it took to accomplish this task. Visit SaneVax
Inc. for more information on HPV vaccines.SaneVax Inc